Literature DB >> 11052978

AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation.

Z P Chen1, G K McConell, B J Michell, R J Snow, B J Canny, B E Kemp.   

Abstract

AMP-activated protein kinase (AMPK) is a metabolic stress-sensing protein kinase responsible for coordinating metabolism and energy demand. In rodents, exercise accelerates fatty acid metabolism, enhances glucose uptake, and stimulates nitric oxide (NO) production in skeletal muscle. AMPK phosphorylates and inhibits acetyl-coenzyme A (CoA) carboxylase (ACC) and enhances GLUT-4 translocation. It has been reported that human skeletal muscle malonyl-CoA levels do not change in response to exercise, suggesting that other mechanisms besides inhibition of ACC may be operating to accelerate fatty acid oxidation. Here, we show that a 30-s bicycle sprint exercise increases the activity of the human skeletal muscle AMPK-alpha1 and -alpha2 isoforms approximately two- to threefold and the phosphorylation of ACC at Ser(79) (AMPK phosphorylation site) approximately 8.5-fold. Under these conditions, there is also an approximately 5.5-fold increase in phosphorylation of neuronal NO synthase-mu (nNOSmu;) at Ser(1451). These observations support the concept that inhibition of ACC is an important component in stimulating fatty acid oxidation in response to exercise and that there is coordinated regulation of nNOSmu to protect the muscle from ischemia/metabolic stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052978     DOI: 10.1152/ajpendo.2000.279.5.E1202

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  74 in total

Review 1.  Physiological adaptations to low-volume, high-intensity interval training in health and disease.

Authors:  Martin J Gibala; Jonathan P Little; Maureen J Macdonald; John A Hawley
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

2.  Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells.

Authors:  Vitor A Lira; Dana L Brown; Ana K Lira; Andreas N Kavazis; Quinlyn A Soltow; Elizabeth H Zeanah; David S Criswell
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

3.  IL-15Rα is a determinant of muscle fuel utilization, and its loss protects against obesity.

Authors:  Emanuele Loro; Erin L Seifert; Cynthia Moffat; Freddy Romero; Manoj K Mishra; Zheng Sun; Predrag Krajacic; Frederick Anokye-Danso; Ross S Summer; Rexford S Ahima; Tejvir S Khurana
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-12       Impact factor: 3.619

Review 4.  The molecular bases of training adaptation.

Authors:  Vernon G Coffey; John A Hawley
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes.

Authors:  Jørgen F P Wojtaszewski; Jesper B Birk; Christian Frøsig; Mads Holten; Henriette Pilegaard; Flemming Dela
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

6.  Human muscle fibre type-specific regulation of AMPK and downstream targets by exercise.

Authors:  Dorte E Kristensen; Peter H Albers; Clara Prats; Otto Baba; Jesper B Birk; Jørgen F P Wojtaszewski
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

Review 7.  Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise.

Authors:  Anand Thirupathi; Claudio Teodoro de Souza
Journal:  J Physiol Biochem       Date:  2017-07-14       Impact factor: 4.158

8.  Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.

Authors:  Melissa M Thomas; David C Wang; Donna M D'Souza; Matthew P Krause; Andrew S Layne; David S Criswell; Hayley M O'Neill; Michael K Connor; Judy E Anderson; Bruce E Kemp; Gregory R Steinberg; Thomas J Hawke
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

9.  Globular adiponectin upregulates nitric oxide production in vascular endothelial cells.

Authors:  Y Hattori; M Suzuki; S Hattori; K Kasai
Journal:  Diabetologia       Date:  2003-10-09       Impact factor: 10.122

10.  Nitric oxide increases cyclic GMP levels, AMP-activated protein kinase (AMPK)alpha1-specific activity and glucose transport in human skeletal muscle.

Authors:  A S Deshmukh; Y C Long; T de Castro Barbosa; H K R Karlsson; S Glund; W J Zavadoski; E M Gibbs; H A Koistinen; H Wallberg-Henriksson; J R Zierath
Journal:  Diabetologia       Date:  2010-03-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.